Multi-step screening of neoantigens’ HLA- and TCR-interfaces improves prediction of survival
Guilhem Richard, Anne S. De Groot, Gary D. Steinberg, Tzintzuni I. Garcia, Alec Kacew, Matthew Ardito, William D. Martin, Gad Berdugo, Michael F. Princiotta, Arjun V. Balar & Randy F. Sweis
EpiVax Therapeutics, Inc, Providence, RI, USA; University of Georgia, Athens, GA, USA; NYU Langone Health, New York, NY, USA; University of Chicago, Chicago, IL, USA
Read an Expert Commentary by Bishoy Faltas, MD